Sign In
×Business
Manufacture of pharmaceuticals and medicine.
Overview
Middle East Pharmaceutical Industries Co. (Avalon Pharma) was established in 1998 as a limited liability company under the name “Middle East Chemical Products Factory Company”, with capital of SAR 500,000. In 2003, the company established Avalon Factory (1) in Riyadh 2nd. Industrial City, and in 2006, the company’s name was changed to “Middle East Pharmaceutical Industries Company”. In 2018, Middle East Distribution Company and its branches were merged into the company. In the following year, the company entered into its first supply and licensing agreement with the Greek’s Elpin Pharmaceutical Inc., under which, Avalon Pharma was authorized to supply and distribute the Greek company’s products in the Kingdom. In 2022, the company was converted into a closed joint-stock company. A year earlier, Avalon Pharma established Avalon Pharma UK Holdings Limited as its first subsidiary in the UK. In the same year, Al-Shamila Distribution Limited Company was merged into the company.
The company’s core activity is developing and manufacturing medicines and pharmaceuticals, as it carries out its activities through three key business segments. The private sector segment, the public sector segment and the export segment. The private sector segment is the major contributor to the company’s revenue. The firm’s revenues are mainly generated from dermatologicals and respiratory system medicines. Avalon Pharma carries out its activities through 70 brands.
Basic Information
City: | Riyadh |
Country | Saudi Arabia |
Ownership Type: | Joint Stock |
Establishment Date: | 1998 |
Commercial Register: | 1010150538 |
Website: | www.avalonpharmaceutical.com |
investor.relations@avalon.com.sa | |
Phone | +966 11 265 3948 |
Fax | +966 11 265 4723 |
Address | Second Industrial Zone - Riyadh 14331 |
PO Box | 3800 |
Argaam Classification
Financials Highlights (M )
Company Size
Trading Data
Stock Market : | TASI |
Fiscal Year End : | December |
Free Float (M) : | - |
Free Float % : | - |
Weight in Index % : | 0.04 |
3M Average Volume : | 511,769 |
3M Average Transactions : | 7,413 |
Change(12M) % : | - |
Major Shareholders
Name | Number of Shares (M) | Holding |
---|---|---|
Tabbaa National Holding Company | 8.44 | 42.18 % |
Talal Youssef Mahmoud Zahid | 2.94 | 14.70 % |
Subsidiaries & Associates
Company | Country | Percentage |
---|---|---|
Avalon Pharma UK Holdings Limited | United Kingdom | 100.00 % |
Investments
Company | Percentage |
---|---|
Columbia Care Inc | 0.02 % |